Interesting conference presentation by IMU CEO (Post #:72852559).
Claims that in-vitro trials of onCARlytics and their recently acquired Azer-Cell CD-19 targeting CAR-T therapy killed all cancer cell lines in 72hrs (which apparently is very fast).
ALA-101 has been shown to be effective in-vitro with onCARlytics (also for solid tumors) although no mention about how long it took, so without the actual data it's difficult to compare with Azer-Cell.
The in-vivo trials ALA-101/onCARlytics will be instructive.
onCARlytics update, page-4
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $168.2M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.5¢ | 15.5¢ | $495.0K | 3.108M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59544 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 114617 | 6 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |